Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

Clinical trial NCT04613453 · TERMINATED

Trial details

NCT number: NCT04613453
Sponsor: Yale University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adolescent Suicide Adolescent Depression

Start date: 2022-01-21
Primary completion: 2024-07-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.